icon-    folder.gif   Conference Reports for NATAP  
  Conference on Retroviruses
and Opportunistic Infections (CROI)
February 22-25, 2016, Boston MA
Back grey_arrow_rt.gif
Global Burden of Cervical Cancer in
HIV-Positive Women on Antiretroviral Therapy
  Reported by Jules Levin
CROI 2016 Feb 22-24 Boston
Combination antiretroviral therapy reduces the detection risk of cervical human papilloma virus infection in women living with HIV..... http://www.natap.org/2014/HIV/120814_03.htm
EACS/2015: Long lasting viral suppression and immune reconstitution (CD4) of great magnitude reduce the risk of cervical dysplasia in HIV-positive women....
http://www.natap.org/2015/EACS/EACS_59.htm......length of time with higher CD4 & <50 HIV viral load decreased risk a lot

Eliane Rohner1, Lukas Butikofer1, Mhairi Maskew2, Yi-Ming A. Chen3, Ruth Friedman4, GypsyamberD'Souza5, Matthias Egger1, Julia Bohlius1for the International Epidemiologic Databases to Evaluate AIDS (IeDEA) and the Collaboration of Observational HIV Epidemiological Research in Europe (COHERE) in EuroCoord.
1University ofBern, Switzerland, 2University ofWitwatersrand, South Africa, 3Kaohsiung Medical University, Taiwan, 4Fundacao Oswaldo Cruz (Fiocruz), Brazil, 5Johns Hopkins Bloomberg School ofPublic Health, USA.